The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 701–800 of 1,004
Yasui, W., Tahara, H., Tahara, E., Fujimoto, J., Nakayama, J., Ishikawa, F., Ide, T., & Tahara, E. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00502.x · Cited by 59
The 5′-End of hTERT mRNA Is a Good Target for Hammerhead Ribozyme to Suppress Telomerase Activity
Yokoyama, Y., Takahashi, Y., Shinohara, A., Wan, X., Takahashi, S., Niwa, K., & Tamaya, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2939 · Cited by 62
Kirkpatrick, K. L., Ogunkolade, W., Elkak, A. E., Bustin, S., Jenkins, P., Ghilchick, M., Newbold, R. F., & Mokbel, K. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021849217054 · Cited by 53
“Human telomerase consists of an RNA subunithuman telomerase RNA (hTR) [7], a protein com-”
BackgroundHoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
Yan, T., Ooi, W. F., Qamra, A., Cheung, A. M. S., Ma, D., Sundaram, G. M., Xu, C., Xing, M., Poon, L.-F., Wang, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02601-1 · Cited by 55
“CRISPR sgRNA used for targeting dCas9-KRAB to HoxC5-binding region are as follows: (1) 5′GGTGTCAGATTACTAGGGCGGGG-3′; (2) 5′-CCCTAGTAATCTGACACCGCAGG-3′; (3) 5′-ACAATGGATCTTACCCACACAGG-3′ and (4) 5′TGTGCTTAGCTGCTGCCAACAGG-3′.”
MethodLiu, Y., Shi, Y., Liu, Y., Pan, X., & Zhang, K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0007-9 · Cited by 57
Ghareghomi, S., Ahmadian, S., Zarghami, N., & Kahroba, H. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.015 · Cited by 55
Seki, K., Suda, T., Aoyagi, Y., Sugawara, S., Natsui, M., Motoyama, H., Shirai, Y., Sekine, T., Kawai, H., Mita, Y., et al. (2001) · PubMed · Cited by 60
Genetic instability in human tumors
Raptis, S., & Bapat, B. V. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7378-4_13 · Cited by 53
“hTERC is ubiquitously expressed in mammalian cells and forms the RNA subunit that provides the template from which telomere synthesis can proceed [ 38 ], while hTERT is the catalytic subunit of telomerase and is expressed solely in cells that display telomerase activity [39].”
BackgroundTelomere length shortening is associated with disease evolution in chronic myelogenous leukemia
Boultwood, J., Fidler, C., Shepherd, P. C. A., Watkins, F., Snowball, J., Haynes, S., Kušec, R., Gaiger, A., Littlewood, T. J., Peniket, A. J., et al. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199905)61:1<26::aid-ajh6>3.0.co;2-r · Cited by 53
Fujimoto, K., & Takahashi, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7806 · Cited by 57
Sealey, D., Zheng, L., Taboski, M. A. S., Cruickshank, J., Ikura, M., & Harrington, L. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1160 · Cited by 68
“Recombinant Trx-HIS6hTERT(1–200) was mixed with radiolabeled single-stranded DNA oligonucleotides containing three full telomeric repeats and subjected to native polyacrylamide gel electrophoresis.”
InfluentialTelomeres, Telomerase and Chromosome Stability
Preston, R. J. (1997) · Radiation Research · doi:10.2307/3579618 · Cited by 57
Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma
Jarboe, E. A., Liaw, K., Thompson, L., Heinz, D. E., Baker, P., McGregor, J. A., Dunn, T. S., Woods, J. E., & Shroyer, K. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205073 · Cited by 54
“…holoenzyme consists of an RNA component, designated hTR, which contains a template region that is complementary to the telomeric DNA repeat (TTAGGG)n , and a single catalytic protein subunit, designated hTERT (Kim et al., 1994; Feng et al., 1995; Nakamura et al., 1997; Meyerson et al., 1997).”
BackgroundFunctional evidence for a telomerase repressor gene on human chromosome 10p15.1
Nishimoto, A., Miura, N., Horikawa, I., Kugoh, H., Murakami, Y., Hirohashi, S., Kawasaki, H., Gazdar, A. F., Shay, J. W., Barrett, J. C., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204165 · Cited by 57
“The telomerase holoenzyme has the RNA component (hTR) containing an internal sequence complementary to the telomeric repeat sequence (Feng et al., 1995) and a catalytic protein component (hTERT) that synthesizes telomeric DNA directly onto the ends of chromosomes by reverse transcription of the RNA…”
BackgroundElayadi, A. N., Demieville, A., Wancewicz, E. V., Monia, B. P., & Corey, D. R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.8.1683 · Cited by 59
“The RNA domain of human telomerase, hTR, contains an 11 base region (nucleotides +46 to + 56) that acts as a template for binding and extending telomeres (14).”
BackgroundVEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent
Bermudez, Y., Yang, H., Saunders, B. O., Cheng, J. Q., Nicosia, S. V., & Kruk, P. A. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.05.005 · Cited by 52
“Both the protein catalytic hTERT and hTR subunits have been identified and cloned, and it is thought that the protein catalytic subunit, hTERT, is the limiting determinant of telomerase activity [6,7].”
BackgroundZavari‐Nematabad, A., Alizadeh‐Ghodsi, M., Hamishehkar, H., Alipour, E., Pilehvar‐Soltanahmadi, Y., & Zarghami, N. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0058-z · Cited by 52
Henderson, Y. C., Breau, R. L., Liu, T.-J., & Clayman, G. L. (2000) · Head & Neck · doi:10.1002/1097-0347(200007)22:4<336::aid-hed4>3.0.co;2-t · Cited by 52
Fujita, Y., Fujikane, T., Fujiuchi, S., Nishigaki, Y., Yamazaki, Y., Nagase, A., Shimizu, T., Ohsaki, Y., & Kikuchi, K. (2003) · Cancer · doi:10.1002/cncr.11611 · Cited by 56
Chen, H.-H., Yu, C., Wang, J., Liu, B.-Y., Wang, Y., Sun, A., Tsai, T.-C., & Chiang, C. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.01.011 · Cited by 62
Inhibition of telomerase by BIBR 1532 and related analogues
Barma, D. K., Elayadi, A. N., Falck, J. R., & Corey, D. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00101-x · Cited by 63
Human Immunodeficiency Virus Type 1 Modulates Telomerase Activity in Peripheral Blood Lymphocytes
Ballon, G., Ometto, L., Righetti, E., Cattelan, A. M., Masiero, S., Zanchetta, M., Chieco‐Bianchi, L., & Rossi, A. D. (2001) · The Journal of Infectious Diseases · doi:10.1086/318072 · Cited by 56
“Telomerase, an RNA-dependent DNA polymerase that synth sizes telomeric repeats [13, 14] and thus prevents progressive telo eric shortening at each cell division [15, 16], is believed to play a determinant role in controlling cell life span and replicative potential [17, 18].”
BackgroundYounes, M., Brown, R. W., Stephenson, M., Gondo, M., & Cagle, P. T. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970915)80:6<1046::aid-cncr6>3.0.co;2-7 · Cited by 381
Ghasemali, S., Nejati‐Koshki, K., Akbarzadeh, A., Tafsiri, E., Zarghami, N., Rahmati-Yamchi, M., Alizadeh, E., Barkhordari, A., Tozihi, M., & Kordi, S. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6949 · Cited by 59
“…hypothesis for replicative senescence, inhibition of telomerase in the malignant cells is expected to result in the erosion of telomeres and lastly leading to growth arrest, senescence or cell death (Feng et al., 1995; Kondo et al., 1998; Hahn et al., 1999; Zhang et al., 1999; Huang et al., 2005).”
BackgroundSaini, N., Srinivasan, R., Chawla, Y. K., Sharma, S., Chakraborti, A., & Rajwanshi, A. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02082.x · Cited by 51
Zhang, Y., Wang, L., & Zhang, C. (2013) · Chemical Communications · doi:10.1039/c3cc48518h · Cited by 51
Steczkiewicz, K., Zimmermann, M. T., Kurciński, M., Lewis, B. A., Dobbs, D. L., Kloczkowski, A., Jernigan, R. L., Koliński, A., & Ginalski, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015399108 · Cited by 51
“Human TER is a structurally complex RNA molecule of 451 nucleotides, containing several conserved sequence and structural motifs (46).”
BackgroundKwon, B. S., Jung, H. S., Song, M.-S., Cho, K. S., Kim, S.-C., Kimm, K., Jeong, J. S., Kim, I.-H., & Lee, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.096 · Cited by 54
Huang, H., Chen, I., Huang, K.-F., Lu, W.-C., Shieh, F.-Y., Huang, Y.-Y., Huang, F.-C., & Lin, J. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.284 · Cited by 51
Sato, N., Maehara, N., Mizumoto, K., Nagai, E., Yasoshima, T., Hirata, K., & Tanaka, M. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3<578::aid-cncr1037>3.0.co;2-w · Cited by 51
Russo, V., Berardinelli, P., Martelli, A., Giacinto, O. D., Nardinocchi, D., Fantasia, D., & Barbara, B. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6603.2006 · Cited by 54
“In fact, telomeric DNA is not completely synthesized by conventional DNA polymerases and, as cells divide, progressive shortening of telomeres occurs (Feng et al. 1995; Zakian 1995).”
BackgroundAmplification of the telomerase reverse transcriptase ( hTERT ) gene in cervical carcinomas
Zhang, A., Zheng, C., Hou, M., Lindvall, C. J., Wallin, K., Ångström, T., Yang, X., Hellström, A., Blennow, E., Björkholm, M., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10071 · Cited by 55
“On the other hand, inhibition of telomerase activity leads to loss of telomeres and subsequent death of HeLa cells derived from cervical carcinoma (Feng et al., 1995).”
BackgroundWang, L., Xiao, H., Zhang, X., Wang, C., & Huang, H. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0061-9 · Cited by 57
“tary to the telomere sequence (TTAGGG)n [9].”
Rb and E2F-1 regulate telomerase activity in human cancer cells
Crowe, D. L., & Nguyen, D. C. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00296-7 · Cited by 55
Herbert, B., Wright, A., Passons, C., Wright, W. E., Ali, I., Kopelovich, L., & Shay, J. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.39 · Cited by 53
“93, No. 1, January 3, 2001 REPORTS 43 (11,47, 48 ).”
Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA
Koga, S., Kondo, Y., Komata, T., & Kondo, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301449 · Cited by 57
N-acetyl transferase 2 genotypes, meat intake and breast cancer risk
Gertig, D. M., Hankinson, S. E., Hough, H., Spiegelman, D., Colditz, G. A., Willett, W. C., Kelsey, K. T., & Hunter, D. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990105)80:1<13::aid-ijc3>3.0.co;2-w · Cited by 101
Martadinata, H., & Phan, A. T. (2014) · Biochemistry · doi:10.1021/bi4015727 · Cited by 50
Huang, F., Chang, C., Lou, P., Kuo, I.-C., Chien, C., Chen, C., Shieh, F.-Y., Chang, T., & Lin, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0260 · Cited by 53
“Discussion In general, inhibitors for telomerase enzyme do not induce cytotoxicity immediately after treatment (8, 35).”
BackgroundInfluentialTelomerase Regulation of Myofibroblast Differentiation
Liu, T., Hu, B., Chung, M. J., Ullenbruch, M., Jin, H., & Phan, S. H. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0252oc · Cited by 48
“Previously successful inhibition of telomerase activity is achieved by introducing antisense human telomerase RNA component expression vector into HeLa cells (31).”
MethodIntegrator is a key component of human telomerase RNA biogenesis
Rubtsova, M. P., Vasilkova, D. P., Moshareva, M. A., Malyavko, A. N., Meerson, M. B., Zatsepin, T. S., Naraykina, Y. V., Beletsky, A. V., Ravin, N. V., & Dontsova, O. A. (2019) · Scientific Reports · doi:10.1038/s41598-018-38297-6 · Cited by 52
Physical activity, a modulator of aging through effects on telomere biology
Semeraro, M. D., Smith, C., Kaiser, M., Levinger, I., Duque, G., Gruber, H.-J., & Herrmann, M. (2020) · Aging · doi:10.18632/aging.103504 · Cited by 49
“expression does not necessarily parallel enzyme activity [44].”
BackgroundStructure of stem‐loop IV of Tetrahymena telomerase RNA
Chen, Y., Fender, J. K., Legassie, J. D., Jarstfer, M. B., Bryan, T. M., & Varani, G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601195 · Cited by 51
“TERT is the catalytic subunit and shares homology to viral reverse transcriptases (Lingner et al, 1997), whereas TER contains the template (Feng et al, 1995).”
BackgroundHigh-Throughput RNAi Screening Reveals Novel Regulators of Telomerase
Cerone, M. A., Burgess, D. J., Naceur-Lombardelli, C., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2734 · Cited by 48
Telomerase Detection in Body Fluids
Hess, J. L., & Highsmith, W. E. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.1.18 · Cited by 58
Krams, M., Hero, B., Berthold, F., Parwaresch, R. M., Harms, D., & Rudolph, P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63896-5 · Cited by 54
“Expression of the catalytic subunit hTERT seems to closely correlate with TA in most tumors(25) whereas the other components seem to be expressed indifferently in tumors and normal tissue.(20,26) We recently investigated the correlation between hTERT expression and TA in a small series of neuroblastomas from which fre…”
BackgroundHarada, K., Kurisu, K., Tahara, H., Tahara, E., Ide, T., & 田原, 榮. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.4.0618 · Cited by 56
Telomerase activity as a measure for monitoring radiocurability of tumor cells
Sawant, S. G., Grégoire, V., Dhar, S., Umbricht, C. B., Cvilic, S., Sukumar, S. V., & Pandita, T. K. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1047 · Cited by 50
“has been cloned (8) and found to have widespread expression.”
Backgroundde Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<96::aid-path989>3.0.co;2-m · Cited by 256
Suda, T., Isokawa, O., Aoyagi, Y., Nomoto, M., Tsukada, K., Shimizu, T., Suzuki, Y., Naito, A., Igarashi, H., Yanagi, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270213 · Cited by 50
Telomerase Activity in Benign and Malignant Epithelial Ovarian Tumors
Wan, M., Li, W., Felix, J. C., Zhao, Y., Dubeau, L., & Duggan, B. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.437 · Cited by 52
“The telomerase assay was preceded by a digestion step with RNase in lanes b. As expected, this procedure resulted in the disappearance of detectable telomerase activity in all positive cases (Fig. 1) because telomerase, which is a ribonucleoprotein, is inactivated by RNase ( 12 ).”
MethodO’Reilly, M., Teichmann, S. A., & Rhodes, D. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80008-6 · Cited by 63
The Role of Telomerase Expression and Telomere Length Maintenance in Human and Mouse
Nan-PIng, W., & Hodes, R. J. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1017223602293 · Cited by 49
“One, termed the telomerase RNA (TER) component, is an RNA that provides a template for synthesis of telomeric DNA repeats (7).”
BackgroundSignaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
Deeb, D., Gao, X., Liu, Y., Varma, N. R. S., Arbab, A. S., & Gautam, S. C. (2013) · Molecules · doi:10.3390/molecules18033250 · Cited by 50
“The human telomerase complex consists of telomerase reverse transcriptase (hTERT), telomerase RNA (TERC), telomerase associated protein-1 (TEP-1), hsp90 and p23 [14–16].”
Criscuolo, F., Smith, S., Zahn, S., Heidinger, B. J., & Haussmann, M. F. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0440 · Cited by 50
Telomeres in neurological disorders
Anitha, A., Thanseem, I., Vasu, M. M., Viswambharan, V., & Poovathinal, S. A. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.01.003 · Cited by 55
Observation of processive telomerase catalysis using high-resolution optical tweezers
Patrick, E. M., Slivka, J. D., Payne, B., Comstock, M., & Schmidt, J. C. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0478-0 · Cited by 56
A Carbazole Derivative Synthesis for Stabilizing the Quadruplex Structure
Chang, C., Wu, J., & Chang, T. (2003) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200300026 · Cited by 49
Protein kinase C modulates telomerase activity in human cervical cancer cells
Kim, Y. W., Hur, S. Y., Kim, T. E., Lee, J. M., Namkoong, S. E., Kim, I.-K., & Kim, J. W. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.27 · Cited by 54
“…telomerase have been cloned: the RNA component of human telomerase which was first identified and functions as a template for telomere elongation (Feng et al., 1995), telomeraseassociated protein 1/telomerase protein component 1 (TP1/TLP1) which is similar to the Tetrahymena telomerase protein…”
MethodRegulation of telomerase during human placental differentiation: a role for TGFβ1
Rama, S., Suresh, Y., & Rao, A. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00550-0 · Cited by 54
Komata, T., Kondo, Y., Koga, S., Ko, S.-C., Chung, L. W. K., & Kondo, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301327 · Cited by 53
Jacobson, O., & Chen, X. S. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007625 · Cited by 50
“Human telomerase activity is associated with the expression of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) (Feng et al., 1995; Nakamura et al., 1997).”
BackgroundDonai, K., Kiyono, T., Eitsuka, T., Guo, Y., Kuroda, K., Sone, H., Isogai, E., & Fukuda, T. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.02.017 · Cited by 49
Tárkányi, I., & Aradi, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.002 · Cited by 52
Localization of Telomerase hTERT Protein and Survivin in Placenta
Lehner, R., Bobak, J. B., Kim, N. W., Shroyer, A. L., & Shroyer, K. R. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200106000-00018 · Cited by 48
Fransson, P., & Widmark, A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<678::aid-cncr18>3.0.co;2-e · Cited by 79
Autexier, C., & Greider, C. W. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.3.787 · Cited by 57
Falchetti, M. L., Larocca, L. M., & Pallini, R. (2002) · Child s Nervous System · doi:10.1007/s00381-002-0562-7 · Cited by 54
“It has been reported that the RNA component is ubiquitously present, even when the enzyme activity is repressed [1].”
BackgroundInfluentialTelomeres: Influencing the Rate of Aging
von Zglinicki, T. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09912.x · Cited by 55
Sallinen, P. K., Miettinen, H., Sallinen, S., Haapasalo, H. K., Helin, H., & Kononen, J. (1997) · Europe PMC (PubMed Central) · Cited by 54
Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications
Matthews, P., Jones, C. J., Skinner, J. W., Haughton, M. F., Micco, C. D., & Wynford‐Thomas, D. (2001) · The Journal of Pathology · doi:10.1002/path.848 · Cited by 52
“In humans, the catalytic component of this enzyme (hTERT) [8–10] is able to synthesize 6 bp repeats using an integral RNA template (hTERC) [11], thus compensating for telomere erosion.”
BackgroundLi, C., Wu, S., Wang, H., Bi, X., Yang, Z., Du, Y., He, L., Cai, Z., Wang, J., & Fan, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.4295 · Cited by 48
“com/oncotarget and telomerase reverse transcriptase (TERT) catalytic subunit [13].”
BackgroundNon-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 48
HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity
Wang, Y.-W., Chang, H., Lin, C.-H., & Yu, W. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.006 · Cited by 51
Soohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 56
Queisser, A., Heeg, S., Thaler, M., von Werder, A., & Opitz, O. G. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.10.001 · Cited by 50
Yang, F., Xian, R. R., Li, Y., Polony, T. S., & BEEMON, K. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709173104 · Cited by 47
Das, A., Banik, N. L., & Ray, S. K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9485-1 · Cited by 50
“Antisense: 50-CTC CTC CAG CGA CTC AAT-30 hTERT Sense: 50-GTA CAT GCG ACA GTT C-30 418 [25]”
BackgroundThe H/ACA complex disrupts triplex in hTR precursor to permit processing by RRP6 and PARN
Tseng, C. K., Wang, H., Schroeder, M. R., & Baumann, P. (2018) · Nature Communications · doi:10.1038/s41467-018-07822-6 · Cited by 49
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
Fan, H., Chen, C., Chi, C.-S., Tsai, J., Chiang, K.-L., Chang, Y., Lin, S., & Harn, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010200 · Cited by 50
“, dyskerin), preserves telomere stability by adding TTAGGG repeats to the end of the given chromosome (capping) in rapidly dividing cells [112,113,116], using its complementary TERC sequence as the template [117], together with TERT subunit as the catalytic component [111].”
Vecoli, C., Borghini, A., & Andreassi, M. G. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108309 · Cited by 49
Telomerase RNA processing: Implications for human health and disease
Nagpal, N., & Agarwal, S. (2020) · Stem Cells · doi:10.1002/stem.3270 · Cited by 48
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
Dorris, K. M. O., Sobo, M., Onar‐Thomas, A., Panditharatna, E., Stevenson, C. B., Gardner, S. L., DeWire, M. D., Pierson, C. R., Olshefski, R. S., Rempel, S. A., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1374-9 · Cited by 48
Toshikuni, N., Nouso, K., Higashi, T., Nakatsukasa, H., Onishi, T., Kaneyoshi, T., Kobayashi, Y., Kariyama, K., Yamamoto, K., & Tsuji, T. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1008 · Cited by 50
“Recently, three components of the telomerase were clo human telomerase RNA component (hTERC), human telome associated protein 1 (hTEP1) and human telomerase revers scriptase (hTERT) (Feng et al, 1995; Harrington et al, 1 Nakamura et al, 1997).”
BackgroundProgressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
Ramirez, R. D., D’Atri, S., Pagani, E., Faraggiana, T., Lacal, P. M., Taylor, R. S., & Shay, J. W. (1999) · Neoplasia · doi:10.1038/sj.neo.7900004 · Cited by 49
Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1
Jagadeesh, S., & Banerjee, P. P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.172 · Cited by 55
Harada, K., Furubo, S., Ozaki, S., Hiramatsu, K., Sudo, Y., & Nakanuma, Y. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00075-1 · Cited by 48
“The predicted size of the PCR product was 178 bp including both RNA polymerase promoter sequences [16].”
BackgroundMethodInfluentialRacek, T., Miše, N., Li, Z., Stoll, A., & Pützer, B. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500193200 · Cited by 52
Jun, E. S., Lee, T. H., Cho, H. H., Suh, S. Y., & Jung, J. S. (2004) · Cellular Physiology and Biochemistry · doi:10.1159/000080335 · Cited by 47
Liu, W., Jiang, J.-F., Xiao, D., & Ding, J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01424-7 · Cited by 47
Humanizing the yeast telomerase template
Henning, K. A., Moskowitz, N. H., Ashlock, M. A., & Liu, P. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5667 · Cited by 54
Telomerase activation in colorectal carcinogenesis
Yan, P., Saraga, E. P., Bouzourene, H., Bosman, F. T., & Benhattar, J. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199910)189:2<207::aid-path424>3.0.co;2-h · Cited by 28
All-Atomic Simulations on Human Telomeric G-Quadruplex DNA Binding with Thioflavin T
Luo, D., & Mu, Y. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b01107 · Cited by 48
G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors
Shalaby, T., Fiaschetti, G., Nagasawa, K., Shin‐ya, K., Baumgartner, M., & Grotzer, M. A. (2013) · Molecules · doi:10.3390/molecules181012500 · Cited by 53
“Human telomerase is composed of two main components, human telomerase RNA (hTR) and telomerase reverse transcriptase TERT [55–58].”
BackgroundLiu, X., Wei, M., Xu, E., Yang, H., Wei, W., Zhang, Y., & Liu, S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.12.054 · Cited by 46
Liao, X., Chen, Y., DeQing, L., Li, F., Li, X., & Jia, W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817655 · Cited by 46
Choi, J., Park, S. H., Park, J., Park, B. G., Cha, S.-J., Kong, K., Lee, K., & Park, A. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.051 · Cited by 50
Telomerase activity in oral cancer
Miyoshi, Y., Tsukinoki, K., Imaizumi, T., Yamada, Y. M. A., Ishizaki, T., Watanabe, Y., Sasakura, Y., Lin, Y., Hosaka, M., & Kubota, Y. (1999) · Oral Oncology · doi:10.1016/s1368-8375(98)00117-1 · Cited by 46
Senescence and immortalization of human cells
Duncan, E. L., Wadhwa, R., & Kaul, S. C. (2000) · Biogerontology · doi:10.1023/a:1010000132671 · Cited by 50
“Similarly, telomerase activation is unlikely to occur via activation of the telomerase RNA component, hTER (Blasco et al. 1995; Feng et al. 1995; Avilion et al. 1996; Ducray et al. 1999).”
Background
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.